SCHEMBL23259131

SCHEMBL23259131

O=C(O)CCCC(=O)N1CCN(c2ccc(OCc3ccccc3)cn2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ME2 P23368 9/20 0.59
ME1 P48163 9/20 0.59
ME3 Q16798 9/20 0.59
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 4/20 0.54
HSD17B10 Q99714 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
TSHR P16473 2/20 0.54
MAPK1 P28482 1/20 0.54
KMT2A Q03164 1/20 0.54
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
HPGD P15428 1/20 0.53
RECQL P46063 1/20 0.53
SLC6A7 Q99884 1/20 0.50
GPR119 Q8TDV5 1/20 0.49
MAPT P10636 1/20 0.47
P4HTM Q9NXG6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12458573 0.85 ME2 (0.59) ME2ME1ME3KDM4EALDH1A1
SCHEMBL23259338 0.85 ME2 (0.59) ME2ME1ME3ALDH1A1HSD17B10
SCHEMBL5214510 0.85 ME2 (0.57) ME2ME1ME3KDM4EALDH1A1
SCHEMBL3802326 0.83 ME2 (0.56) ME2ME1ME3ALDH1A1HSD17B10
SCHEMBL2357897 0.82 ME2 (0.55) ME2ME1ME3KDM4EALDH1A1
SCHEMBL23244278 0.81 ME2 (0.70) ME2ME1ME3KDM4EALDH1A1
SCHEMBL24358702 0.79 EPHX2 (0.51) ME2ME1ME3ALDH1A1SMN1; SMN2
SCHEMBL2312197 0.79 GPR119 (0.52) ME2ME1ME3KDM4EALDH1A1
SCHEMBL1103897 0.78 GPR119 (0.76) ME2ME1ME3SLC6A7GPR119
SCHEMBL30931813 0.78 GPR119 (0.76) ME2ME1ME3SLC6A7GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127266-A1 MALIC ENZYME INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-04-28 US disclosed
US-11225480-B2 Malic enzyme inhibitors SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-01-18 US disclosed
US-20210115038-A1 MALIC ENZYME INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2021-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115038-A1 MALIC ENZYME INHIBITORS ME1, ME2, ME3 ME2 2/4885ME1 1/4885ME3 3/4885
US-11225480-B2 Malic enzyme inhibitors ME1, RNASE1, ME2 ME2 3/4885ME1 1/4885ME3 4/4885
US-20220127266-A1 MALIC ENZYME INHIBITORS ME1, ME2, ME3 ME2 2/4885ME1 1/4885ME3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.